- Home
- CNSP vs MTNB Comparison
CNSP vs MTNB Comparison
Compare CNSP & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- MTNB
- Stock Information
- Founded
- CNSP 2017
- MTNB 2013
- Country
- CNSP United States
- MTNB United States
- Employees
- CNSP N/A
- MTNB N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- CNSP Health Care
- MTNB Health Care
- Exchange
- CNSP Nasdaq
- MTNB Nasdaq
- Market Cap
- CNSP 5.6M
- MTNB 5.2M
- IPO Year
- CNSP 2019
- MTNB N/A
- Fundamental
- Price
- CNSP $8.82
- MTNB $0.93
- Analyst Decision
- CNSP Hold
- MTNB Hold
- Analyst Count
- CNSP 1
- MTNB 1
- Target Price
- CNSP N/A
- MTNB N/A
- AVG Volume (30 Days)
- CNSP 27.0K
- MTNB 52.1K
- Earning Date
- CNSP 08-13-2025
- MTNB 08-13-2025
- Dividend Yield
- CNSP N/A
- MTNB N/A
- EPS Growth
- CNSP N/A
- MTNB N/A
- EPS
- CNSP N/A
- MTNB N/A
- Revenue
- CNSP N/A
- MTNB N/A
- Revenue This Year
- CNSP N/A
- MTNB N/A
- Revenue Next Year
- CNSP N/A
- MTNB N/A
- P/E Ratio
- CNSP N/A
- MTNB N/A
- Revenue Growth
- CNSP N/A
- MTNB N/A
- 52 Week Low
- CNSP $7.72
- MTNB $0.47
- 52 Week High
- CNSP $744.00
- MTNB $8.75
- Technical
- Relative Strength Index (RSI)
- CNSP 37.72
- MTNB 48.75
- Support Level
- CNSP $7.72
- MTNB $0.94
- Resistance Level
- CNSP $9.62
- MTNB $1.04
- Average True Range (ATR)
- CNSP 0.86
- MTNB 0.07
- MACD
- CNSP -0.13
- MTNB -0.01
- Stochastic Oscillator
- CNSP 29.99
- MTNB 20.07
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.